SlideShare a Scribd company logo
1 of 43
Overview of  Clostridium Difficile  Infections (CDI) Stephen M. Brecher Ph.D. VA Boston HealthCare System BU School of Medicine
The opinions expressed in this presentation are those of the presenter and do not necessarily represent the views of the Veterans Affairs Health- Care System
Overview ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Historical Perspective ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
“ Antibiotic Associated Pseudomembranous Colitis Due to Toxin-Producing Bacteria” 1 ,[object Object],[object Object],[object Object],[object Object],[object Object]
Factors That Complicated the Discovery of CDI ,[object Object],[object Object],[object Object]
Clostridium difficile ,[object Object],[object Object],[object Object],[object Object]
Source of Infections ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Risk Factors for Infection ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Role of Antibiotics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Incidence in The United States ,[object Object],[object Object],[object Object]
Pathogenesis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Pathogenesis of CDI Asymptomatic  C. difficile  colonization C. difficile  exposure Antimicrobial C. difficile  infection Hospitalization From Johnson S, Gerding DN.  Clin Infect Dis.  1998;26:1027-1036; with permission.
Pathogenesis Changing Epidemiology ,[object Object],[object Object],[object Object],[object Object]
Epidemic Strain ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Adapted from McDonald LC, et al.  N Engl J Med.  2005;353:2433-2441; with permission.
In Vitro  Production of Toxins  in Epidemic Strain From Warny M, et al.  Lancet .  2005;366:1079-1084; with permission.
Not So Fast ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Should You Treat the Patient or Treat the Strain? ,[object Object],[object Object],[object Object]
Symptoms of CDI ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Markers of Severe Disease ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Laboratory Diagnosis of CDI Laboratory  Diagnosis Enzyme Immunoassay (EIA) Glutamate  Dehydrogenase (GDH) Cell Culture  Neutralization  Assay (CCNA) Toxigenic Culture  (Culture and CCNA) Molecular Based (PCR Or LAMP) Stool Culture
Specimen and Testing Guidelines ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
“Plate Sin With Gold and it Goes Untarnished”
Cell Culture Neutralization Assay Performance Revisited * Compared to toxigenic culture.  +  Compared to clinical case definition and multiple test methods. Slide provided by Dr. Karen Carroll Study Method Sensitivity (%) Specificity (%) Eastwood, et al. JCM 2009; 47:3211 In house Vero cell assay* 86.4 99.2 Barbut, et al. JCM 2009;47:1276 In house MRC-5 cells* 75.8 100 Stamper, et al JCM 2009;47:373 TechLab TOX-B test* 67.2 99.1 Peterson, et al. CID 2007;45:1152 In house MRC-5 cells + 76.7 97.1
Conflicting Results with EIA ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Recently Published EIA Papers (1-6) Parameter Range Sensitivity 32  –  98.7% Specificity 92  –  100% PPV 76.4  –  96% NPV 88  –  100%
My Opinion ,[object Object],[object Object],[object Object],[object Object]
C. Diff Quik Chek Complete ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Commercially Available  Molecular  Assays Slide provided by Dr. Susan Novak-Weekley akSli Assay Target Instrument TAT ,[object Object],ToxinB SmartCycler Amplification 75-120 min ,[object Object],Toxin B easyMag extraction SmartCycler Amplification ~ 3 hrs ,[object Object],[object Object],Toxin B (RUO IDs 027/BIstrains) GeneXpert 45 min Meridian Illumigene conserved 5’ sequence of the  tcdA  gene  illumigene Incubator/reader 45 min
BD GeneOhm™ Cdiff Assay  Procedure Overview Definitive On-screen Results Results in <2 Hours Stool Specimen Slide courtesy BD GeneOhm lideS provide Specimen Preparation Lysis - DNA Extraction Reconstitution Of Reagents Real-time PCR Analysis on the SmartCycler ®
pro GASTRO ™  Cd Workflow Specimens Clarified Stool 110 µl of nucleic acid for analysis Add buffer, Vortex & spin Slide courtesy Gen-Probe Dilute Internal Control. Combine 20 µl clarified stool and 10 µl  Internal Control   Run Lysis, Add Beads Perform extraction and elute in 110 µl
pro GASTRO ™  Cd Workflow Hands-on Time =  57 min Hands-off Time = 137 min  TOTAL TIME  = 194 min Slide courtesy Gen-Probe Extracted nucleic acid Prepare controls Combine 5 µl of nucleic acid & 20 µl of Mastermix in reaction tube Insert each reaction tube in SmartCycler  Program instrument and run assay Mastermix
Xpert ®   C. difficile  PCR Test for  Clostridium difficile  Toxin B Only Results in an early as 30 minutes; assay complete in 45 minutes If negative
[object Object],[object Object],[object Object],[object Object],Slide Courtesy of  Meridian Assay Protocol
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Slide Courtesy of  Meridian Assay Protocol
Summary of  C. difficile  PCR Published Data Slide courtesy of Dr. Susan Novak-Weekley Publication  PCR Assay Sens/Spec Terhes, 2009 BD vs. Tox Culture* 96%/99%   Not all negatives specimens tested by culture*.  Stamper, 2009 BD vs. Tox Culture  83.6%/98.2% Eastwood, 2009 BD vs. CCCN BD vs. Tox Culture 92.2%/94% 88.5%/95.4% Kvach, 2010 BD vs. Tox Culture* 91.4%/100%  Not all negatives specimens tested by culture*.  Stamper, 2009 Prodesse vs. Tox Culture 77.3%/99.2% Huang, 2009 Cepheid Xpert vs. CCCN 97.1%/93.9% Novak-Weekley, 2010 Cepheid Xpert vs. Tox Culture 94.4%/96.3% Swindells, 2010 Cepheid Xpert vs Tox Culture BD vs Tox culture 100%/99.2% 94.4%/99.2%,  Small “N”
Illumigene ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Consequences of Bad Tests ,[object Object],[object Object],[object Object],[object Object],[object Object]
My Recommendations ,[object Object],[object Object],[object Object],[object Object],[object Object]
Treatments ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Bacteriotherapy Fecal Transplantation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Infection Control  (short course) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Summary ,[object Object],[object Object],[object Object],[object Object],[object Object]
Y Chromosome ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Gitschier, J., Science, 1993 (261) p. 679

More Related Content

What's hot

グラム陰性菌菌血症治療期間
グラム陰性菌菌血症治療期間グラム陰性菌菌血症治療期間
グラム陰性菌菌血症治療期間Shungo Yamamoto
 
Ivermectin for the treatment of covid
Ivermectin for the treatment of covidIvermectin for the treatment of covid
Ivermectin for the treatment of coviddr_dediet
 
Tb sure ultra short july 2019
Tb sure ultra short july 2019Tb sure ultra short july 2019
Tb sure ultra short july 2019PathKind Labs
 
IDSA antifungal guideline ver 2
IDSA antifungal guideline ver 2IDSA antifungal guideline ver 2
IDSA antifungal guideline ver 2YuTian Hsieh
 
Typhoid conjugate vaccines in India - Aug 2015
Typhoid conjugate vaccines in India -  Aug 2015Typhoid conjugate vaccines in India -  Aug 2015
Typhoid conjugate vaccines in India - Aug 2015Gaurav Gupta
 
Zyvac tcv noida aug 2018 - Completely indigenous Typhoid Vaccine - with a Quiz
Zyvac tcv noida aug 2018 - Completely indigenous Typhoid Vaccine - with a QuizZyvac tcv noida aug 2018 - Completely indigenous Typhoid Vaccine - with a Quiz
Zyvac tcv noida aug 2018 - Completely indigenous Typhoid Vaccine - with a QuizGaurav Gupta
 
Development of monoclonal antibodies Workshop
Development of monoclonal antibodies WorkshopDevelopment of monoclonal antibodies Workshop
Development of monoclonal antibodies WorkshopAngel Hernández
 
重症病患抗生素使用961113
重症病患抗生素使用961113重症病患抗生素使用961113
重症病患抗生素使用961113calaf0618
 

What's hot (19)

グラム陰性菌菌血症治療期間
グラム陰性菌菌血症治療期間グラム陰性菌菌血症治療期間
グラム陰性菌菌血症治療期間
 
nature14411
nature14411nature14411
nature14411
 
CDI 2019
CDI 2019CDI 2019
CDI 2019
 
Ss16
Ss16Ss16
Ss16
 
Pathology
PathologyPathology
Pathology
 
thesis final ppt
thesis final pptthesis final ppt
thesis final ppt
 
Ivermectin for the treatment of covid
Ivermectin for the treatment of covidIvermectin for the treatment of covid
Ivermectin for the treatment of covid
 
Tb sure ultra short july 2019
Tb sure ultra short july 2019Tb sure ultra short july 2019
Tb sure ultra short july 2019
 
Laboratory diagnosis of primary immunodeficiencies
Laboratory diagnosis of primary immunodeficienciesLaboratory diagnosis of primary immunodeficiencies
Laboratory diagnosis of primary immunodeficiencies
 
IDSA antifungal guideline ver 2
IDSA antifungal guideline ver 2IDSA antifungal guideline ver 2
IDSA antifungal guideline ver 2
 
Typhoid conjugate vaccines in India - Aug 2015
Typhoid conjugate vaccines in India -  Aug 2015Typhoid conjugate vaccines in India -  Aug 2015
Typhoid conjugate vaccines in India - Aug 2015
 
1200 j lipman
1200 j lipman1200 j lipman
1200 j lipman
 
Austin Internal Medicine
Austin Internal MedicineAustin Internal Medicine
Austin Internal Medicine
 
SEYED MOHAMMADREZA Hashemian IFI
SEYED MOHAMMADREZA Hashemian IFISEYED MOHAMMADREZA Hashemian IFI
SEYED MOHAMMADREZA Hashemian IFI
 
Zyvac tcv noida aug 2018 - Completely indigenous Typhoid Vaccine - with a Quiz
Zyvac tcv noida aug 2018 - Completely indigenous Typhoid Vaccine - with a QuizZyvac tcv noida aug 2018 - Completely indigenous Typhoid Vaccine - with a Quiz
Zyvac tcv noida aug 2018 - Completely indigenous Typhoid Vaccine - with a Quiz
 
Development of monoclonal antibodies Workshop
Development of monoclonal antibodies WorkshopDevelopment of monoclonal antibodies Workshop
Development of monoclonal antibodies Workshop
 
C.difficile
C.difficileC.difficile
C.difficile
 
重症病患抗生素使用961113
重症病患抗生素使用961113重症病患抗生素使用961113
重症病患抗生素使用961113
 
Unravelling fungal immunity through primary immune deficiencies
Unravelling fungal immunity through primary immune deficienciesUnravelling fungal immunity through primary immune deficiencies
Unravelling fungal immunity through primary immune deficiencies
 

Viewers also liked

Crohns symposium mathew philps beyond biologicals
Crohns symposium mathew philps  beyond biologicalsCrohns symposium mathew philps  beyond biologicals
Crohns symposium mathew philps beyond biologicalsrrsolution
 
Bokk+final+du+10+juin+2011
Bokk+final+du+10+juin+2011Bokk+final+du+10+juin+2011
Bokk+final+du+10+juin+2011Association LIR
 
Vegetables nutrition fondation-louis-bonduelle
Vegetables nutrition fondation-louis-bonduelleVegetables nutrition fondation-louis-bonduelle
Vegetables nutrition fondation-louis-bonduelleFondation Louis Bonduelle
 
La Consommation de fruits et légumes en Europe - Laura Fernandez, Fondation L...
La Consommation de fruits et légumes en Europe - Laura Fernandez, Fondation L...La Consommation de fruits et légumes en Europe - Laura Fernandez, Fondation L...
La Consommation de fruits et légumes en Europe - Laura Fernandez, Fondation L...Fondation Louis Bonduelle
 
From N=1 to N=100: What I Have Learned from Quantifying My Superorganism Body
From N=1 to N=100: What I Have Learned from Quantifying My Superorganism BodyFrom N=1 to N=100: What I Have Learned from Quantifying My Superorganism Body
From N=1 to N=100: What I Have Learned from Quantifying My Superorganism BodyLarry Smarr
 
Prévention de l'obésité chez l'enfant - Dr Judit Répasy, Fondation L. Bonduelle
Prévention de l'obésité chez l'enfant - Dr Judit Répasy, Fondation L. BonduellePrévention de l'obésité chez l'enfant - Dr Judit Répasy, Fondation L. Bonduelle
Prévention de l'obésité chez l'enfant - Dr Judit Répasy, Fondation L. BonduelleFondation Louis Bonduelle
 
Fondation louis bonduelle_communiqué_presse_monographie_biologie_vegetale_ogm
Fondation louis bonduelle_communiqué_presse_monographie_biologie_vegetale_ogmFondation louis bonduelle_communiqué_presse_monographie_biologie_vegetale_ogm
Fondation louis bonduelle_communiqué_presse_monographie_biologie_vegetale_ogmFondation Louis Bonduelle
 
Légumes & Population frannçaise - Lionel LAFAY, Fondation L. Bonduelle
Légumes & Population frannçaise - Lionel LAFAY, Fondation L. BonduelleLégumes & Population frannçaise - Lionel LAFAY, Fondation L. Bonduelle
Légumes & Population frannçaise - Lionel LAFAY, Fondation L. BonduelleFondation Louis Bonduelle
 
Les composés oxygénés
Les composés oxygénésLes composés oxygénés
Les composés oxygénésmisstambouille
 
Alimentation personnes-agees-rencontres-fondation-louis-bonduelle-juin-2012
Alimentation personnes-agees-rencontres-fondation-louis-bonduelle-juin-2012Alimentation personnes-agees-rencontres-fondation-louis-bonduelle-juin-2012
Alimentation personnes-agees-rencontres-fondation-louis-bonduelle-juin-2012Fondation Louis Bonduelle
 
Jb prajapati 080315
Jb prajapati 080315Jb prajapati 080315
Jb prajapati 080315neerjayakult
 
Gahmj%2 e2014%2e019
Gahmj%2 e2014%2e019Gahmj%2 e2014%2e019
Gahmj%2 e2014%2e019Cheryl Penna
 
Comment faire aimer les légumes aux enfants ?
Comment faire aimer les légumes aux enfants ?Comment faire aimer les légumes aux enfants ?
Comment faire aimer les légumes aux enfants ?Fondation Louis Bonduelle
 
A systems biology approach to irritable bowel syndrome
A systems biology approach to irritable bowel syndromeA systems biology approach to irritable bowel syndrome
A systems biology approach to irritable bowel syndromeYounis I Munshi
 

Viewers also liked (20)

Crohns symposium mathew philps beyond biologicals
Crohns symposium mathew philps  beyond biologicalsCrohns symposium mathew philps  beyond biologicals
Crohns symposium mathew philps beyond biologicals
 
Paper 30
Paper 30Paper 30
Paper 30
 
Bokk+final+du+10+juin+2011
Bokk+final+du+10+juin+2011Bokk+final+du+10+juin+2011
Bokk+final+du+10+juin+2011
 
Vegetables nutrition fondation-louis-bonduelle
Vegetables nutrition fondation-louis-bonduelleVegetables nutrition fondation-louis-bonduelle
Vegetables nutrition fondation-louis-bonduelle
 
La Consommation de fruits et légumes en Europe - Laura Fernandez, Fondation L...
La Consommation de fruits et légumes en Europe - Laura Fernandez, Fondation L...La Consommation de fruits et légumes en Europe - Laura Fernandez, Fondation L...
La Consommation de fruits et légumes en Europe - Laura Fernandez, Fondation L...
 
Rir 10th june_2011_v2
Rir 10th june_2011_v2Rir 10th june_2011_v2
Rir 10th june_2011_v2
 
From N=1 to N=100: What I Have Learned from Quantifying My Superorganism Body
From N=1 to N=100: What I Have Learned from Quantifying My Superorganism BodyFrom N=1 to N=100: What I Have Learned from Quantifying My Superorganism Body
From N=1 to N=100: What I Have Learned from Quantifying My Superorganism Body
 
Prévention de l'obésité chez l'enfant - Dr Judit Répasy, Fondation L. Bonduelle
Prévention de l'obésité chez l'enfant - Dr Judit Répasy, Fondation L. BonduellePrévention de l'obésité chez l'enfant - Dr Judit Répasy, Fondation L. Bonduelle
Prévention de l'obésité chez l'enfant - Dr Judit Répasy, Fondation L. Bonduelle
 
Fondation louis bonduelle_communiqué_presse_monographie_biologie_vegetale_ogm
Fondation louis bonduelle_communiqué_presse_monographie_biologie_vegetale_ogmFondation louis bonduelle_communiqué_presse_monographie_biologie_vegetale_ogm
Fondation louis bonduelle_communiqué_presse_monographie_biologie_vegetale_ogm
 
Monographie regulation-appetit-satiete
Monographie regulation-appetit-satieteMonographie regulation-appetit-satiete
Monographie regulation-appetit-satiete
 
Légumes & Population frannçaise - Lionel LAFAY, Fondation L. Bonduelle
Légumes & Population frannçaise - Lionel LAFAY, Fondation L. BonduelleLégumes & Population frannçaise - Lionel LAFAY, Fondation L. Bonduelle
Légumes & Population frannçaise - Lionel LAFAY, Fondation L. Bonduelle
 
Les composés oxygénés
Les composés oxygénésLes composés oxygénés
Les composés oxygénés
 
Projeto Biosfera Da Energia Social Resume
Projeto Biosfera Da Energia Social ResumeProjeto Biosfera Da Energia Social Resume
Projeto Biosfera Da Energia Social Resume
 
Nrgastro.2013.259
Nrgastro.2013.259Nrgastro.2013.259
Nrgastro.2013.259
 
Alimentation personnes-agees-rencontres-fondation-louis-bonduelle-juin-2012
Alimentation personnes-agees-rencontres-fondation-louis-bonduelle-juin-2012Alimentation personnes-agees-rencontres-fondation-louis-bonduelle-juin-2012
Alimentation personnes-agees-rencontres-fondation-louis-bonduelle-juin-2012
 
Jb prajapati 080315
Jb prajapati 080315Jb prajapati 080315
Jb prajapati 080315
 
Nrgastro.2011.247
Nrgastro.2011.247Nrgastro.2011.247
Nrgastro.2011.247
 
Gahmj%2 e2014%2e019
Gahmj%2 e2014%2e019Gahmj%2 e2014%2e019
Gahmj%2 e2014%2e019
 
Comment faire aimer les légumes aux enfants ?
Comment faire aimer les légumes aux enfants ?Comment faire aimer les légumes aux enfants ?
Comment faire aimer les légumes aux enfants ?
 
A systems biology approach to irritable bowel syndrome
A systems biology approach to irritable bowel syndromeA systems biology approach to irritable bowel syndrome
A systems biology approach to irritable bowel syndrome
 

Similar to Overview of Clostridium Difficile Infections (CDI

Garey-Austin-ELC-Presentation-022416.pptx
Garey-Austin-ELC-Presentation-022416.pptxGarey-Austin-ELC-Presentation-022416.pptx
Garey-Austin-ELC-Presentation-022416.pptxSahil922200
 
Antibiotic associated diarrhea
Antibiotic associated diarrheaAntibiotic associated diarrhea
Antibiotic associated diarrheaSamir Haffar
 
abbreviated C.diff COCA presentation (long)
abbreviated C.diff COCA presentation (long)abbreviated C.diff COCA presentation (long)
abbreviated C.diff COCA presentation (long)C M
 
Koch To Quantiferon
Koch To QuantiferonKoch To Quantiferon
Koch To Quantiferonjamieritchey
 
Microbiome & Infection Control - NJ Fawcett
Microbiome & Infection Control - NJ FawcettMicrobiome & Infection Control - NJ Fawcett
Microbiome & Infection Control - NJ FawcettNicola Fawcett
 
Hospital Presentation
Hospital Presentation Hospital Presentation
Hospital Presentation apollohealing
 
Invasive candidiasis the hidden cause of sepsis
Invasive candidiasis the hidden cause of sepsisInvasive candidiasis the hidden cause of sepsis
Invasive candidiasis the hidden cause of sepsisKhaled Taema
 
abbreviated C.diff COCA presentation (short)
abbreviated C.diff COCA presentation (short)abbreviated C.diff COCA presentation (short)
abbreviated C.diff COCA presentation (short)C M
 
literature review on research work on c. difficile
literature review on research work on c. difficileliterature review on research work on c. difficile
literature review on research work on c. difficileTahura Mariyam Ansari
 
Clostridium difficile: C. diff is more difficult than ever - presentation by ...
Clostridium difficile: C. diff is more difficult than ever - presentation by ...Clostridium difficile: C. diff is more difficult than ever - presentation by ...
Clostridium difficile: C. diff is more difficult than ever - presentation by ...IN 30 MINUTES Guides
 
Changing epidimeology by jahanzaib.pptx
Changing epidimeology by jahanzaib.pptxChanging epidimeology by jahanzaib.pptx
Changing epidimeology by jahanzaib.pptxAbdulAleemAwan1
 
Faecal transplantation for the treatment of c. defficle associated disease
Faecal transplantation for the treatment of c. defficle associated disease Faecal transplantation for the treatment of c. defficle associated disease
Faecal transplantation for the treatment of c. defficle associated disease Anjum Hashmi MPH
 
401 06 cdd_and_probiotics(1)
401 06 cdd_and_probiotics(1)401 06 cdd_and_probiotics(1)
401 06 cdd_and_probiotics(1)Luis Barrera
 
401 06 cdd_and_probiotics(rgfrgr1)
401 06 cdd_and_probiotics(rgfrgr1)401 06 cdd_and_probiotics(rgfrgr1)
401 06 cdd_and_probiotics(rgfrgr1)Luis Barrera
 
Webinar: Defeating Superbugs: Hospitals on the Front Lines
Webinar: Defeating Superbugs: Hospitals on the Front Lines Webinar: Defeating Superbugs: Hospitals on the Front Lines
Webinar: Defeating Superbugs: Hospitals on the Front Lines Modern Healthcare
 
Malattie infiammatorie intestinali
Malattie infiammatorie intestinaliMalattie infiammatorie intestinali
Malattie infiammatorie intestinaliASMaD
 

Similar to Overview of Clostridium Difficile Infections (CDI (20)

Garey-Austin-ELC-Presentation-022416.pptx
Garey-Austin-ELC-Presentation-022416.pptxGarey-Austin-ELC-Presentation-022416.pptx
Garey-Austin-ELC-Presentation-022416.pptx
 
Antibiotic associated diarrhea
Antibiotic associated diarrheaAntibiotic associated diarrhea
Antibiotic associated diarrhea
 
abbreviated C.diff COCA presentation (long)
abbreviated C.diff COCA presentation (long)abbreviated C.diff COCA presentation (long)
abbreviated C.diff COCA presentation (long)
 
Koch To Quantiferon
Koch To QuantiferonKoch To Quantiferon
Koch To Quantiferon
 
Clostridium difficile 2010
Clostridium difficile 2010Clostridium difficile 2010
Clostridium difficile 2010
 
Microbiome & Infection Control - NJ Fawcett
Microbiome & Infection Control - NJ FawcettMicrobiome & Infection Control - NJ Fawcett
Microbiome & Infection Control - NJ Fawcett
 
Jin2
Jin2Jin2
Jin2
 
Hospital Presentation
Hospital Presentation Hospital Presentation
Hospital Presentation
 
Invasive candidiasis the hidden cause of sepsis
Invasive candidiasis the hidden cause of sepsisInvasive candidiasis the hidden cause of sepsis
Invasive candidiasis the hidden cause of sepsis
 
abbreviated C.diff COCA presentation (short)
abbreviated C.diff COCA presentation (short)abbreviated C.diff COCA presentation (short)
abbreviated C.diff COCA presentation (short)
 
literature review on research work on c. difficile
literature review on research work on c. difficileliterature review on research work on c. difficile
literature review on research work on c. difficile
 
Clostridium difficile: C. diff is more difficult than ever - presentation by ...
Clostridium difficile: C. diff is more difficult than ever - presentation by ...Clostridium difficile: C. diff is more difficult than ever - presentation by ...
Clostridium difficile: C. diff is more difficult than ever - presentation by ...
 
Changing epidimeology by jahanzaib.pptx
Changing epidimeology by jahanzaib.pptxChanging epidimeology by jahanzaib.pptx
Changing epidimeology by jahanzaib.pptx
 
Faecal transplantation for the treatment of c. defficle associated disease
Faecal transplantation for the treatment of c. defficle associated disease Faecal transplantation for the treatment of c. defficle associated disease
Faecal transplantation for the treatment of c. defficle associated disease
 
Tuberculosis
Tuberculosis Tuberculosis
Tuberculosis
 
10821.ppt
10821.ppt10821.ppt
10821.ppt
 
401 06 cdd_and_probiotics(1)
401 06 cdd_and_probiotics(1)401 06 cdd_and_probiotics(1)
401 06 cdd_and_probiotics(1)
 
401 06 cdd_and_probiotics(rgfrgr1)
401 06 cdd_and_probiotics(rgfrgr1)401 06 cdd_and_probiotics(rgfrgr1)
401 06 cdd_and_probiotics(rgfrgr1)
 
Webinar: Defeating Superbugs: Hospitals on the Front Lines
Webinar: Defeating Superbugs: Hospitals on the Front Lines Webinar: Defeating Superbugs: Hospitals on the Front Lines
Webinar: Defeating Superbugs: Hospitals on the Front Lines
 
Malattie infiammatorie intestinali
Malattie infiammatorie intestinaliMalattie infiammatorie intestinali
Malattie infiammatorie intestinali
 

More from Eastern Pennsylvania Branch ASM

Shiga toxin Producing Escherichia coli-Nancy Strockbine PhD
Shiga toxin Producing Escherichia coli-Nancy Strockbine PhDShiga toxin Producing Escherichia coli-Nancy Strockbine PhD
Shiga toxin Producing Escherichia coli-Nancy Strockbine PhDEastern Pennsylvania Branch ASM
 
Multidrug Resistance malaria vani vannappagari mbbs ph d
Multidrug Resistance malaria vani vannappagari mbbs ph dMultidrug Resistance malaria vani vannappagari mbbs ph d
Multidrug Resistance malaria vani vannappagari mbbs ph dEastern Pennsylvania Branch ASM
 
Molecular Epidemiology of Mycobacterium tuberculosis-Barry Kreiswirth PhD
Molecular Epidemiology of Mycobacterium tuberculosis-Barry Kreiswirth PhDMolecular Epidemiology of Mycobacterium tuberculosis-Barry Kreiswirth PhD
Molecular Epidemiology of Mycobacterium tuberculosis-Barry Kreiswirth PhDEastern Pennsylvania Branch ASM
 
Gram negative cephalosporium and carbapenem resistance robert bonomo md
Gram negative cephalosporium and carbapenem resistance   robert bonomo mdGram negative cephalosporium and carbapenem resistance   robert bonomo md
Gram negative cephalosporium and carbapenem resistance robert bonomo mdEastern Pennsylvania Branch ASM
 
Galveston National Laboratory-Emerging Diseases- Jim LeDuc PhD
Galveston National Laboratory-Emerging Diseases- Jim LeDuc PhDGalveston National Laboratory-Emerging Diseases- Jim LeDuc PhD
Galveston National Laboratory-Emerging Diseases- Jim LeDuc PhDEastern Pennsylvania Branch ASM
 
Dynamic Epidemiology of Streptococcus pneumoniae- Joshua Metlay MD PhD
Dynamic Epidemiology of Streptococcus pneumoniae- Joshua Metlay MD PhDDynamic Epidemiology of Streptococcus pneumoniae- Joshua Metlay MD PhD
Dynamic Epidemiology of Streptococcus pneumoniae- Joshua Metlay MD PhDEastern Pennsylvania Branch ASM
 
Recent Changes in Gram negative Resistance - Dr Steve Jenkins - November 2010...
Recent Changes in Gram negative Resistance - Dr Steve Jenkins - November 2010...Recent Changes in Gram negative Resistance - Dr Steve Jenkins - November 2010...
Recent Changes in Gram negative Resistance - Dr Steve Jenkins - November 2010...Eastern Pennsylvania Branch ASM
 
CLSI Antimicrobial Susceptibility Update - Janet Hindler - November Symposium...
CLSI Antimicrobial Susceptibility Update - Janet Hindler - November Symposium...CLSI Antimicrobial Susceptibility Update - Janet Hindler - November Symposium...
CLSI Antimicrobial Susceptibility Update - Janet Hindler - November Symposium...Eastern Pennsylvania Branch ASM
 
MRSA Screening-Non molecular vs molecular testing - Dr Gerri Hall - November ...
MRSA Screening-Non molecular vs molecular testing - Dr Gerri Hall - November ...MRSA Screening-Non molecular vs molecular testing - Dr Gerri Hall - November ...
MRSA Screening-Non molecular vs molecular testing - Dr Gerri Hall - November ...Eastern Pennsylvania Branch ASM
 
New Molecular Approaches to Identify 21st Century Microbes - Dr Melissa Mille...
New Molecular Approaches to Identify 21st Century Microbes - Dr Melissa Mille...New Molecular Approaches to Identify 21st Century Microbes - Dr Melissa Mille...
New Molecular Approaches to Identify 21st Century Microbes - Dr Melissa Mille...Eastern Pennsylvania Branch ASM
 

More from Eastern Pennsylvania Branch ASM (12)

Shiga toxin Producing Escherichia coli-Nancy Strockbine PhD
Shiga toxin Producing Escherichia coli-Nancy Strockbine PhDShiga toxin Producing Escherichia coli-Nancy Strockbine PhD
Shiga toxin Producing Escherichia coli-Nancy Strockbine PhD
 
Multidrug Resistant Malaria- Vani Vannappagari MBBS PhD
Multidrug Resistant Malaria- Vani Vannappagari MBBS PhDMultidrug Resistant Malaria- Vani Vannappagari MBBS PhD
Multidrug Resistant Malaria- Vani Vannappagari MBBS PhD
 
Multidrug Resistance malaria vani vannappagari mbbs ph d
Multidrug Resistance malaria vani vannappagari mbbs ph dMultidrug Resistance malaria vani vannappagari mbbs ph d
Multidrug Resistance malaria vani vannappagari mbbs ph d
 
Molecular Epidemiology of Mycobacterium tuberculosis-Barry Kreiswirth PhD
Molecular Epidemiology of Mycobacterium tuberculosis-Barry Kreiswirth PhDMolecular Epidemiology of Mycobacterium tuberculosis-Barry Kreiswirth PhD
Molecular Epidemiology of Mycobacterium tuberculosis-Barry Kreiswirth PhD
 
Gram negative cephalosporium and carbapenem resistance robert bonomo md
Gram negative cephalosporium and carbapenem resistance   robert bonomo mdGram negative cephalosporium and carbapenem resistance   robert bonomo md
Gram negative cephalosporium and carbapenem resistance robert bonomo md
 
Galveston National Laboratory-Emerging Diseases- Jim LeDuc PhD
Galveston National Laboratory-Emerging Diseases- Jim LeDuc PhDGalveston National Laboratory-Emerging Diseases- Jim LeDuc PhD
Galveston National Laboratory-Emerging Diseases- Jim LeDuc PhD
 
Dynamic Epidemiology of Streptococcus pneumoniae- Joshua Metlay MD PhD
Dynamic Epidemiology of Streptococcus pneumoniae- Joshua Metlay MD PhDDynamic Epidemiology of Streptococcus pneumoniae- Joshua Metlay MD PhD
Dynamic Epidemiology of Streptococcus pneumoniae- Joshua Metlay MD PhD
 
HIV History and Future - Kathleen Squires MD
HIV History and Future - Kathleen Squires MDHIV History and Future - Kathleen Squires MD
HIV History and Future - Kathleen Squires MD
 
Recent Changes in Gram negative Resistance - Dr Steve Jenkins - November 2010...
Recent Changes in Gram negative Resistance - Dr Steve Jenkins - November 2010...Recent Changes in Gram negative Resistance - Dr Steve Jenkins - November 2010...
Recent Changes in Gram negative Resistance - Dr Steve Jenkins - November 2010...
 
CLSI Antimicrobial Susceptibility Update - Janet Hindler - November Symposium...
CLSI Antimicrobial Susceptibility Update - Janet Hindler - November Symposium...CLSI Antimicrobial Susceptibility Update - Janet Hindler - November Symposium...
CLSI Antimicrobial Susceptibility Update - Janet Hindler - November Symposium...
 
MRSA Screening-Non molecular vs molecular testing - Dr Gerri Hall - November ...
MRSA Screening-Non molecular vs molecular testing - Dr Gerri Hall - November ...MRSA Screening-Non molecular vs molecular testing - Dr Gerri Hall - November ...
MRSA Screening-Non molecular vs molecular testing - Dr Gerri Hall - November ...
 
New Molecular Approaches to Identify 21st Century Microbes - Dr Melissa Mille...
New Molecular Approaches to Identify 21st Century Microbes - Dr Melissa Mille...New Molecular Approaches to Identify 21st Century Microbes - Dr Melissa Mille...
New Molecular Approaches to Identify 21st Century Microbes - Dr Melissa Mille...
 

Recently uploaded

Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night EnjoyCall Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoybabeytanya
 
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune)  Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune)  Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls ServiceMiss joya
 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Servicevidya singh
 
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomLucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomdiscovermytutordmt
 
High Profile Call Girls Coimbatore Saanvi☎️ 8250192130 Independent Escort Se...
High Profile Call Girls Coimbatore Saanvi☎️  8250192130 Independent Escort Se...High Profile Call Girls Coimbatore Saanvi☎️  8250192130 Independent Escort Se...
High Profile Call Girls Coimbatore Saanvi☎️ 8250192130 Independent Escort Se...narwatsonia7
 
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.MiadAlsulami
 
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safenarwatsonia7
 
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore EscortsVIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escortsaditipandeya
 
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...narwatsonia7
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...Garima Khatri
 
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...Miss joya
 
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...Taniya Sharma
 
Aspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliAspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliRewAs ALI
 
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...Miss joya
 
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...CALL GIRLS
 
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night EnjoyCall Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoybabeytanya
 
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipurparulsinha
 

Recently uploaded (20)

Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night EnjoyCall Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
 
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune)  Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune)  Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls Service
 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
 
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomLucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
 
High Profile Call Girls Coimbatore Saanvi☎️ 8250192130 Independent Escort Se...
High Profile Call Girls Coimbatore Saanvi☎️  8250192130 Independent Escort Se...High Profile Call Girls Coimbatore Saanvi☎️  8250192130 Independent Escort Se...
High Profile Call Girls Coimbatore Saanvi☎️ 8250192130 Independent Escort Se...
 
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
 
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
 
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore EscortsVIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
 
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
 
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Servicesauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
 
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
 
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
 
Aspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliAspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas Ali
 
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
 
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
 
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night EnjoyCall Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoy
 
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
 
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCREscort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
 

Overview of Clostridium Difficile Infections (CDI

  • 1. Overview of Clostridium Difficile Infections (CDI) Stephen M. Brecher Ph.D. VA Boston HealthCare System BU School of Medicine
  • 2. The opinions expressed in this presentation are those of the presenter and do not necessarily represent the views of the Veterans Affairs Health- Care System
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13. Pathogenesis of CDI Asymptomatic C. difficile colonization C. difficile exposure Antimicrobial C. difficile infection Hospitalization From Johnson S, Gerding DN. Clin Infect Dis. 1998;26:1027-1036; with permission.
  • 14.
  • 15.
  • 16. In Vitro Production of Toxins in Epidemic Strain From Warny M, et al. Lancet . 2005;366:1079-1084; with permission.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21. Laboratory Diagnosis of CDI Laboratory Diagnosis Enzyme Immunoassay (EIA) Glutamate Dehydrogenase (GDH) Cell Culture Neutralization Assay (CCNA) Toxigenic Culture (Culture and CCNA) Molecular Based (PCR Or LAMP) Stool Culture
  • 22.
  • 23. “Plate Sin With Gold and it Goes Untarnished”
  • 24. Cell Culture Neutralization Assay Performance Revisited * Compared to toxigenic culture. + Compared to clinical case definition and multiple test methods. Slide provided by Dr. Karen Carroll Study Method Sensitivity (%) Specificity (%) Eastwood, et al. JCM 2009; 47:3211 In house Vero cell assay* 86.4 99.2 Barbut, et al. JCM 2009;47:1276 In house MRC-5 cells* 75.8 100 Stamper, et al JCM 2009;47:373 TechLab TOX-B test* 67.2 99.1 Peterson, et al. CID 2007;45:1152 In house MRC-5 cells + 76.7 97.1
  • 25.
  • 26.
  • 27.
  • 28.
  • 29. BD GeneOhm™ Cdiff Assay Procedure Overview Definitive On-screen Results Results in <2 Hours Stool Specimen Slide courtesy BD GeneOhm lideS provide Specimen Preparation Lysis - DNA Extraction Reconstitution Of Reagents Real-time PCR Analysis on the SmartCycler ®
  • 30. pro GASTRO ™ Cd Workflow Specimens Clarified Stool 110 µl of nucleic acid for analysis Add buffer, Vortex & spin Slide courtesy Gen-Probe Dilute Internal Control. Combine 20 µl clarified stool and 10 µl Internal Control Run Lysis, Add Beads Perform extraction and elute in 110 µl
  • 31. pro GASTRO ™ Cd Workflow Hands-on Time = 57 min Hands-off Time = 137 min TOTAL TIME = 194 min Slide courtesy Gen-Probe Extracted nucleic acid Prepare controls Combine 5 µl of nucleic acid & 20 µl of Mastermix in reaction tube Insert each reaction tube in SmartCycler Program instrument and run assay Mastermix
  • 32. Xpert ® C. difficile PCR Test for Clostridium difficile Toxin B Only Results in an early as 30 minutes; assay complete in 45 minutes If negative
  • 33.
  • 34.
  • 35. Summary of C. difficile PCR Published Data Slide courtesy of Dr. Susan Novak-Weekley Publication PCR Assay Sens/Spec Terhes, 2009 BD vs. Tox Culture* 96%/99% Not all negatives specimens tested by culture*. Stamper, 2009 BD vs. Tox Culture 83.6%/98.2% Eastwood, 2009 BD vs. CCCN BD vs. Tox Culture 92.2%/94% 88.5%/95.4% Kvach, 2010 BD vs. Tox Culture* 91.4%/100% Not all negatives specimens tested by culture*. Stamper, 2009 Prodesse vs. Tox Culture 77.3%/99.2% Huang, 2009 Cepheid Xpert vs. CCCN 97.1%/93.9% Novak-Weekley, 2010 Cepheid Xpert vs. Tox Culture 94.4%/96.3% Swindells, 2010 Cepheid Xpert vs Tox Culture BD vs Tox culture 100%/99.2% 94.4%/99.2%, Small “N”
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.
  • 42.
  • 43.

Editor's Notes

  1. Slide Originally, it was thought that the administration of antimicrobial therapy following asymptomatic colonization resulted in C. difficile -associated diarrhea. However, later findings suggested that patients who are colonized with C. difficile are at a reduced risk of developing active infection. 1 Those data led to the revised hypothesis of C. difficile pathogenesis, as shown in this slide. After hospitalization or admission to a long-term healthcare facility, patients are at an increased risk of exposure to C. difficile. The administration of antimicrobials or other agents that may alter the colonic flora (eg, chemotherapy) render the patient susceptible and lead to the development of C. difficile disease, asymptomatic C. difficile colonization, or nothing. The incubation period after exposure in a susceptible patient is less than 1 week. 1 Do not exclude the diagnosis of C. difficile in patients who have received other agents that can potentially alter the colonic flora. (This is the exception; the vast majority of patients with CDI will have received antimicrobials.) Johnson S, Gerding DN. Clostridium difficile -associated diarrhea. Clin Infect Dis. 1998;26:1027-1036.
  2. Slide The CDC has reported a new strain of C. difficile . 3 Various methods of classification exist for the epidemic strain. The epidemic strain is characterized as toxinotype III, North American pulsed-field gel electrophoresis (PFGE) type 1, and polymerase chain reaction (PCR)-ribotype 027 (NAP1/027). 1 In Quebec, the strain is classified as Pulsovar A and was determined to be identical to NAP1. 2 This new strain produces both toxin A and toxin B and they are not “missed” by laboratories that use toxin A immunoassays. This strain has caused multiple recent outbreaks of C. difficile infection across the United States and in Montreal, Canada, and the United Kingdom. Other features of the new strain include high-level resistance to fluoroquinolones, which may be related to increased virulence. 2,4 The epidemic strain also produces binary toxin. However, the significance of binary toxin is unknown at this time. This strain appears to produce greater amounts of toxins A and B and has a deletion in the tcdC gene, which potentially downregulates toxin production. 1 This slide shows the polymorphisms and deletions in the tcdC variants that have been identified in toxinotype III strains (the tcdC protein may downregulate the production of toxins A and B), which may result in a decreased ability to regulate toxin production, causing dramatically increased amounts of toxins A and B. This association requires further verification. 4-6 Warny M, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet . 2005;366:1079-1084. Hubert B, et al. A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile -associated disease in Quebec. Clin Infect Dis. 2007;44:238-244. CDC. Frequently asked questions about a new strain of Clostridium difficile. Fact Sheet, July 2005. McDonald LC, et al. An epidemic, toxin gene-variant strain of Clostridium difficile . N Engl J Med. 2005;353:2433-2441. Spigaglia P, Mastrantonio P. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol . 2002;40:3470-3475. Rupnik M, et al. Revised nomenclature of Clostridium difficile toxins and associated genes. J Med Microbiol. 2005;54:113-117.
  3. Slide The figure depicts the in vitro production of toxins A and B by C. difficile isolates of toxinotype 0 (red line) and toxinotype III (blue line). These data are based on observations published recently by Warny and colleagues using isolates from 124 patients with CDAD in Quebec, Canada. Additional isolates from recent outbreaks were obtained from the US Centers for Disease Control and Prevention, Montreal, and the United Kingdom. As shown, the peak concentration of toxin A was 16 times higher in the toxinotype III strain than in type 0 strains, and the concentration of toxin B was 23 times higher. Furthermore, control strains (type 0) produced toxin during the stationary phase, whereas type III strains produced toxin during the log and stationary phases. 1 Warny M, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet . 2005;366:1079-1084.
  4. Swindell et al paper Xpert = 19 Pos, BDGO = 18 Pos